NASDAQ · HITI
High Tide Inc.
$2.66-$0.03 (-1.12%)
High Tide Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.02% below the high.
Loading market information…
NASDAQ · WGRX · USD
Stock price, earnings
Quote as of Jul 21, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Wellgistics Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.39% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Wellgistics Health, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.66-$0.03 (-1.12%)
High Tide Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.02% below the high.
$1.18-$0.01 (-0.84%)
PetMed Express, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.22% below the high.
$1.99+$0.19 (+10.56%)
Pomdoctor Limited’s quoted price sits in the lower half of its reported 52-week range, 98.28% below the high.
$3.50-$0.39 (-10.03%)
ARB IOT Group Limited’s quoted price sits in the lower half of its reported 52-week range, 67.2% below the high.
$3.49+$0.09 (+2.65%)
Scienture Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 87.42% below the high.
$0.51+$0.02 (+5.11%)
Gelteq Limited Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 74.83% below the high.
$2.19+$0.01 (+0.44%)
Cellyan Biotechnology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 92.45% below the high.
$0.98-$0.08 (-7.79%)
BioNexus Gene Lab Corp.’s quoted price sits in the lower half of its reported 52-week range, 82.72% below the high.
